REG3β modifies cell tumor function by impairing extracellular vesicle uptake

Area of Science:

• Cell Biology
• Cancer Research
• Biochemistry

Background:

• Extracellular vesicles (EVs) are crucial intercellular messengers involved in physiological and pathological processes, including cancer.
• Pancreatic ductal adenocarcinoma (PDAC) is a complex disease where tumor microenvironment interactions play a significant role.

Purpose of the Study:

• To investigate the role of REG3β, a lectin secreted by healthy pancreatic tissue, in modulating EV-mediated communication in PDAC.
• To elucidate how REG3β affects EV uptake and downstream signaling in the context of pancreatic cancer.

Main Methods:

• In vitro studies using cell cultures to assess the impact of REG3β on EV internalization and signaling.
• In vivo experiments in animal models to evaluate the effect of REG3β on EV distribution and tumor progression.
• Analysis of circulating EVs in blood samples from pancreatic cancer patients.

Main Results:

• REG3β binds to glycoproteins on EVs, hindering their uptake by target cells.
• Disruption of EV signaling by REG3β inhibits macrophage phenotypic switch, reduces cancer cell migration, and reverses EV-induced metabolomic changes.
• In vivo, REG3β impairs tumor cell uptake of EVs, leading to increased circulating REG3β+ EVs in PDAC patients.

Conclusions:

• REG3β, secreted by healthy pancreatic tissue, acts as a modulator of EV-mediated intercellular communication in PDAC.
• This lectin interferes with cancer cell progression by inhibiting EV uptake and downstream effects.
• The findings offer insights into the complex interactions within the PDAC tumor microenvironment and suggest potential therapeutic targets.